Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that a productive in-person meeting with the FDA on August 15, 2024, resulted in a positive outcome regarding the EvieMED Ring's wellness features and metrics. Following this development, the Company will be working with the agency to move forward w ...